PMID- 33679689 OWN - NLM STAT- MEDLINE DCOM- 20210617 LR - 20210617 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 11 DP - 2020 TI - Microarray-Based Allergy Diagnosis: Quo Vadis? PG - 594978 LID - 10.3389/fimmu.2020.594978 [doi] LID - 594978 AB - More than 30% of the world population suffers from allergy. Allergic individuals are characterized by the production of immunoglobulin E (IgE) antibodies against innocuous environmental allergens. Upon allergen recognition IgE mediates allergen-specific immediate and late-phase allergic inflammation in different organs. The identification of the disease-causing allergens by demonstrating the presence of allergen-specific IgE is the key to precision medicine in allergy because it allows tailoring different forms of prevention and treatment according to the sensitization profiles of individual allergic patients. More than 30 years ago molecular cloning started to accelerate the identification of the disease-causing allergen molecules and enabled their production as recombinant molecules. Based on recombinant allergen molecules, molecular allergy diagnosis was introduced into clinical practice and allowed dissecting the molecular sensitization profiles of allergic patients. In 2002 it was demonstrated that microarray technology allows assembling large numbers of allergen molecules on chips for the rapid serological testing of IgE sensitizations with small volumes of serum. Since then microarrayed allergens have revolutionized research and diagnosis in allergy, but several unmet needs remain. Here we show that detection of IgE- and IgG-reactivity to a panel of respiratory allergens microarrayed onto silicon elements is more sensitive than glass-based chips. We discuss the advantages of silicon-based allergen microarrays and how this technology will allow addressing hitherto unmet needs in microarray-based allergy diagnosis. Importantly, it described how the assembly of silicon microarray elements may create different microarray formats for suiting different diagnostic applications such as quick testing of single patients, medium scale testing and fully automated large scale testing. CI - Copyright (c) 2021 Huang, Campana, Akinfenwa, Curin, Sarzsinszky, Karsonova, Riabova, Karaulov, Niespodziana, Elisyutina, Fedenko, Litovkina, Smolnikov, Khaitov, Vrtala, Schlederer and Valenta. FAU - Huang, Huey-Jy AU - Huang HJ AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Campana, Raffaela AU - Campana R AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Akinfenwa, Oluwatoyin AU - Akinfenwa O AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Curin, Mirela AU - Curin M AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Sarzsinszky, Eszter AU - Sarzsinszky E AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Karsonova, Antonina AU - Karsonova A AD - Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical University, Moscow, Russia. FAU - Riabova, Ksenja AU - Riabova K AD - Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical University, Moscow, Russia. FAU - Karaulov, Alexander AU - Karaulov A AD - Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical University, Moscow, Russia. FAU - Niespodziana, Katarzyna AU - Niespodziana K AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Elisyutina, Olga AU - Elisyutina O AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. FAU - Fedenko, Elena AU - Fedenko E AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. FAU - Litovkina, Alla AU - Litovkina A AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. FAU - Smolnikov, Evgenii AU - Smolnikov E AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. FAU - Khaitov, Musa AU - Khaitov M AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. FAU - Vrtala, Susanne AU - Vrtala S AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Schlederer, Thomas AU - Schlederer T AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. FAU - Valenta, Rudolf AU - Valenta R AD - Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. AD - Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical University, Moscow, Russia. AD - Department of Allergology and Clinical Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia. AD - Karl Landsteiner University of Health Sciences, Krems, Austria. LA - eng GR - P 29398/FWF_/Austrian Science Fund FWF/Austria PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20210212 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Allergens) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Allergens/*chemistry MH - Humans MH - Hypersensitivity/*blood/*diagnosis MH - Immunoglobulin E/*blood MH - *Protein Array Analysis PMC - PMC7928321 OTO - NOTNLM OT - IgE OT - allergen OT - allergen chip OT - allergy OT - microarrayed allergens OT - molecular diagnosis OT - precision medicine COIS- RV has received research grants from HVD Life Science, Vienna, Austria, and Viravaxx, Vienna, Austria, and serves as a consultant for Viravaxx. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/03/09 06:00 MHDA- 2021/06/22 06:00 PMCR- 2020/01/01 CRDT- 2021/03/08 05:50 PHST- 2020/08/20 00:00 [received] PHST- 2020/12/08 00:00 [accepted] PHST- 2021/03/08 05:50 [entrez] PHST- 2021/03/09 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2020.594978 [doi] PST - epublish SO - Front Immunol. 2021 Feb 12;11:594978. doi: 10.3389/fimmu.2020.594978. eCollection 2020.